Penumbra (NYSE:PEN) posted second-quarter results this week that beat the overall consensus on Wall Street.
The Alameda, Calif.-based company reported profits of $9.2 million, or 25¢ per share, on sales of $184.3 million for the three months ended June 30, for a sales growth of 75.3% compared with Q2 2020.
Get the full story on our sister site, Medical Tubing + Extrusion.